Pre-market hot trades in US stocks: iOthree pre-market up 8.03%, clear capital flow, market sentiment is high but volatility needs to be cautious

Popular Pre-Market Trades in US Stocks iOthree, up 8.03% in pre-market, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Top Gainers in Pre-Market US Stocks Fengzhong Global, up 132.93% in pre-market. Based on recent news, On April 3, Fengzhong Global announced a new product release, stating that its latest smart home device is about to launch. The product features innovative functions and technology, and the market response has been positive, driving the stock price significantly higher. On April 2, the company released its latest quarterly financial report, showing that both its revenue and profit exceeded market expectations. The report indicated a 50% year-on-year revenue growth and a 60% increase in net profit, which boosted investor confidence and further pushed up the stock price. On April 1, Fengzhong Global received an important patent authorization, which will help the company gain a favorable position in future market competition. The acquisition of the patent is seen as a reflection of the company's technological strength, attracting a large number of investors to buy the stock. The smart home industry has performed strongly recently, with robust market demand. Profusa, up 113.72% in pre-market. Based on recent news, On April 6, Profusa announced the signing of a letter of intent to acquire BioInsights' PanOmics molecular diagnostics platform, with a transaction amount of approximately $30 million in an all-stock deal. This move gives Profusa exclusive rights to the technology and allows for the validation of new diagnostic tests using clinical samples, with a primary focus on pancreatic cancer. This news significantly boosted the stock price. On April 6, Profusa announced an expansion of its collaboration with the Mayo Clinic to utilize the PanOmics platform to monitor patients before and after pancreatic surgery. This collaboration enhances the company's credibility and growth potential in the medical market, further driving up the stock price. On April 6, Profusa plans to raise additional funds to expand its diagnostics business. The company stated it would raise operational funds through the issuance of convertible notes, which also had a positive impact on the stock price. The medical technology industry has performed strongly recently, with significant capital inflow. Xiao i Robot, up 63.58% in pre-market, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation